Ibrutinib Impurity 27 | CAS 1642630-12-3 - Request Quote
Ibrutinib Impurity 27
| SZ CAT No: | SZ-I005046-(Hide) |
| CAS No | 1642630-12-3 |
| Mol.F. | C22H22N6O |
| Mol.Wt. |
386.5 |
| Inv. Status |
Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Ibrutinib Impurity 27 is chemically (S)-3-(4-Phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine. Ibrutinib Impurity 27 is supplied with detailed characterization data compliant with regulatory guideline. Ibrutinib Impurity 27 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ibrutinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1642630-12-3
Purchase 1642630-12-3
Order 1642630-12-3
Enquire 1642630-12-3
price of 1642630-12-3
1642630-12-3 Supplier
1642630-12-3 Manufacturer
1642630-12-3 Exporter
buy high quality Ibrutinib Impurity 27
Purchase Ibrutinib Impurity 27
Ibrutinib Impurity 27 suppliers
Ibrutinib Impurity 27 manufacturers
Ibrutinib Impurity 27 price
Order Ibrutinib Impurity 27
Enquire Ibrutinib Impurity 27
Ibrutinib Impurity 27 cost
Ibrutinib Impurity 27 Supplier
Ibrutinib Impurity 27 Distributor
Ibrutinib Impurity 27 for Method Validation
Ibrutinib Reference Standard
Ibrutinib Impurity 27 for ANDA Filing
Ibrutinib Impurity 27 for Forced Degradation Studies
Ibrutinib Impurity 27 Identification Standards
Ibrutinib Impurity 27 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.